GREENWICH BIOSCIENCES, INC. for GREENWICH BIOSCIENCES, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 21, 2019 | $380,000 | Replaced |
| 3rd Quarter - Amendment | Nov 4, 2019 | $390,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALICE P. MEAD | — |
| DEBORAH LYNN WALTER | — |
Consumer Issues/Safety/Products CSP
FY2020 Omnibus Appropriations Bill - Issues related to patient safety, product regulations, and FDA enforcement; FDA regulation of cannabidiol in medicines and consumer products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALICE P. MEAD | — |
| DEBORAH LYNN WALTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.